---
schema_version: "secwatch.filing_event.v1"
accession: "0001703057-23-000014"
form_type: "8-K"
ticker: "ABCL"
cik: "0001703057"
company_name: "AbCellera Biologics Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:25:46.336408+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# AbCellera shareholders elect directors, ratify auditor, approve say-on-pay at 2023 annual meeting

## Summary
- John S. Montalbano elected with 167.3M for, 11.0M against; Peter Thiel with 131.2M for, 47.0M against.
- Ratification of KPMG as auditor approved: 201.0M for, 0.3M against, 0.2M abstain.
- Non-binding say-on-pay compensation approved: 159.4M for, 18.6M against, 0.4M abstain.
- Total shares outstanding at record date: 288.7M; broker non-votes on director and say-on-pay: 23.0M.

## SEC filing metadata
- accession: 0001703057-23-000014
- form_type: 8-K
- ticker: ABCL
- cik: 0001703057
- company_name: AbCellera Biologics Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703057/000170305723000014/0001703057-23-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703057/000170305723000014/abcl-20230615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001703057-23-000014
- JSON: https://secwatch.observer/filing/0001703057-23-000014.json
- Plain text: https://secwatch.observer/filing/0001703057-23-000014.txt

## Key facts
- Shareholder Votes
  AbCellera Biologics Inc. shareholders approved Election of John S. Montalbano, CFA and Peter Thiel as class III directors at the 2023-06-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: The Company’s shareholders voted for the class III directors as follows: Nominee For Against Abstain John S. Montalbano, CFA 167,257,682 10,997,867 165,946 Peter Thiel 131,151,160 47,033,189 237,146 The broker non-votes for this Proposal 1 totaled 23,048,328 common shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703057/000170305723000014/0001703057-23-000014-index.htm
- Shareholder Votes
  AbCellera Biologics Inc. shareholders approved Ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: The votes cast at the Annual Meeting were as follows: For Against Abstain 200,983,540 299,897 186,386
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703057/000170305723000014/0001703057-23-000014-index.htm
- Shareholder Votes
  AbCellera Biologics Inc. shareholders approved Approve on a non-binding advisory basis the compensation of the Company’s named executive officers (Say-on-Pay) at the 2023-06-15 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: The votes cast at the Annual Meeting were as follows: For Against Abstain 159,440,607 18,625,842 355,046 The broker non-votes for this Proposal 3 totaled 23,048,328 common shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703057/000170305723000014/0001703057-23-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.